| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ellen M Gravallese | Q117258216 |
| P2860 | cites work | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice | Q24536131 | ||
| Macrophages express osteopontin during repair of myocardial necrosis | Q24676436 | ||
| Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis | Q28214727 | ||
| OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
| Receptor-ligand interaction between CD44 and osteopontin (Eta-1) | Q28647297 | ||
| Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression | Q34451146 | ||
| Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis | Q35140465 | ||
| Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts | Q42490864 | ||
| Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin | Q42501998 | ||
| Comment on "The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease" | Q73155267 | ||
| Cutting edge: Attenuated experimental autoimmune encephalomyelitis in eta-1/osteopontin-deficient mice | Q77671445 | ||
| Osteopontin expression and function: role in bone remodeling | Q77808019 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 147-149 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Osteopontin: a bridge between bone and the immune system. | |
| P478 | volume | 112 |
| Q37076880 | A Contra Capture Protein Array Platform for Studying Post-translationally Modified (PTM) Auto-antigenomes |
| Q64123328 | An antibody-free sample pretreatment method for osteopontin combined with MALDI-TOF MS/MS analysis |
| Q39463117 | Analysis of HDAC1-mediated regulation of Runx2-induced osteopontin gene expression in C3h10t1/2 cells |
| Q33618811 | Association between secreted phosphoprotein-1 (SPP1) polymorphisms and low bone mineral density in women |
| Q34667586 | Blockade of osteopontin reduces alloreactive CD8+ T cell-mediated graft-versus-host disease |
| Q36403383 | CD44 is a determinant of inflammatory bone loss |
| Q51334502 | Calciprotein particles as potential etiologic agents of idiopathic preterm birth. |
| Q61927929 | Chapter 6 Vascular Calcification Inhibitors In Relation To Cardiovascular Disease With Special Emphasis On Fetuin‐A In Chronic Kidney Disease |
| Q36334580 | Clinical relevance of aortic calcification in urolithiasis patients. |
| Q85902703 | Comparison of gene expression between mandibular and iliac bone-derived cells |
| Q33433741 | Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia. |
| Q41771247 | Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species |
| Q37639340 | Environmental Factors Impacting Bone-Relevant Chemokines. |
| Q47394908 | Exploring molecular mechanism of bone-forming capacity of Eurycoma longifolia: Evidence of enhanced expression of bone-related biomarkers. |
| Q82663771 | Expression of IL-17A in human atherosclerotic lesions is associated with increased inflammation and plaque vulnerability |
| Q54614874 | Gene expression profiling of human alveolar macrophages of phenotypically normal smokers and nonsmokers reveals a previously unrecognized subset of genes modulated by cigarette smoking. |
| Q43492539 | Haplotype analysis revealed a genetic influence of osteopontin on large artery atherosclerosis |
| Q89146429 | High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes |
| Q46446999 | Homology modeling based solution structure of Hoxc8-DNA complex: role of context bases outside TAAT stretch |
| Q37121507 | Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis |
| Q35913508 | Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage |
| Q41181689 | Loss of Bone Mineral Density Associated with Age in Male Rats Fed on Sunflower Oil Is Avoided by Virgin Olive Oil Intake or Coenzyme Q Supplementation. |
| Q40185259 | Loss of osteopontin perturbs the epithelial-mesenchymal transition in an injured mouse lens epithelium |
| Q36850368 | MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes |
| Q28261120 | Mineral chaperones: a role for fetuin-A and osteopontin in the inhibition and regression of pathologic calcification |
| Q26783466 | Molecular targets in arthritis and recent trends in nanotherapy |
| Q37973770 | Monogenic autoimmunity |
| Q83171260 | Opn: key regulator of pDC interferon production |
| Q43109071 | Osteopontin Deficiency Suppresses Tumor Necrosis Factor-α-Induced Apoptosis in Chondrocytes |
| Q37253109 | Osteopontin Promotes Expression of Matrix Metalloproteinase 13 through NF-κB Signaling in Osteoarthritis |
| Q38425912 | Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence |
| Q40219737 | Osteopontin dysregulation and lytic bone lesions in multiple myeloma. |
| Q28307824 | Osteopontin expression by CD103- dendritic cells drives intestinal inflammation |
| Q37050067 | Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. |
| Q35758917 | Osteopontin inhibits HIF-2α mRNA expression in osteoarthritic chondrocytes |
| Q28505299 | Osteopontin is a novel marker of pancreatic ductal tissues and of undifferentiated pancreatic precursors in mice |
| Q36937276 | Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway |
| Q36162995 | Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies |
| Q30835675 | Pathways of aging: comparative analysis of gene signatures in replicative senescence and stress induced premature senescence |
| Q44557093 | Phosphorylation of osteopontin in osteoarthritis degenerative cartilage and its effect on matrix metalloprotease 13. |
| Q51841062 | Plasma level of Osteopontin does not respond to total replacement Surgery in patients with severe Primary knee/Hip Osteoarthritis. |
| Q46817487 | Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients |
| Q47392961 | Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy |
| Q37793154 | Regulatory Effects of Interferon-β on Osteopontin and Interleukin-17 Expression in Multiple Sclerosis |
| Q37716786 | Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. |
| Q38333417 | Role of adaptive immunity in alcoholic liver disease |
| Q33700555 | Role of osteopontin in amplification and perpetuation of rheumatoid synovitis |
| Q38243936 | Role of osteopontin in rheumatoid arthritis |
| Q27006644 | Role of osteopontin in systemic lupus erythematosus |
| Q46861953 | Serum levels of osteopontin are increased in SIRS and sepsis. |
| Q36324913 | Skeletal development, bone remodeling, and hematopoiesis |
| Q35125558 | Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. |
| Q42811866 | Stimulation of osteoblasts with Emdogain increases the expression of specific mineralization markers |
| Q47744416 | Surface-dependent modulation of proliferation, bone matrix molecules, and inflammatory factors in human osteoblasts |
| Q36689220 | Targeting leukocyte trafficking to inflamed skin: still an attractive therapeutic approach? |
| Q24628875 | The Dietary Supplement Protandim® Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular DystrophyMdxMice |
| Q33540190 | The RGD domain of human osteopontin promotes tumor growth and metastasis through activation of survival pathways |
| Q37542237 | The Role of Osteopontin in the Pathogenesis and Complications of Type 1 Diabetes Mellitus in Children |
| Q36007649 | The influence of calcitonin gene-related peptide on markers of bone metabolism in MG-63 osteoblast-like cells co-cultured with THP-1 macrophage-like cells under virtually osteolytic conditions |
| Q45231843 | The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population. |
| Q84356840 | The possible roles of OPN-regulated CEACAM1 expression in promoting the survival of activated T cells and the apoptosis of oral keratinocytes in oral lichen planus patients |
| Q96134698 | The preliminary association study of osteopontin 707 C/T polymorphism with systemic lupus erythematosus in a Polish population |
| Q36324969 | The role of the immune system in the pathophysiology of osteoporosis |
| Q33346360 | Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells |
| Q51989273 | Ultrastructural and immunocytochemical analyses of osteopontin in reactionary and reparative dentine formed after extrusion of upper rat incisors. |
| Q36676122 | Vascular calcification and osteoporosis--from clinical observation towards molecular understanding |
Search more.